Myocardial Infarction Clinical Trials

310 recruitingLast updated: June 18, 2026

There are 310 actively recruiting myocardial infarction clinical trials across 51 countries. Studies span Not Applicable, Phase 4, Phase 3, Phase 2, Early Phase 1, Phase 1. Top locations include Seoul, South Korea, London, United Kingdom, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Myocardial Infarction Trials at a Glance

310 actively recruiting trials for myocardial infarction are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 114 trials, with the heaviest enrollment activity in Seoul, London, and Beijing. Lead sponsors running myocardial infarction studies include Assistance Publique - Hôpitaux de Paris, Queen Mary University of London, and Chonnam National University Hospital.

Browse myocardial infarction trials by phase

Treatments under study

About Myocardial Infarction Clinical Trials

Looking for clinical trials for Myocardial Infarction? There are currently 123 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Myocardial Infarction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Myocardial Infarction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 310 trials

Recruiting
Not Applicable

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI-2 Trial

ST-elevation Myocardial Infarction (STEMI)Primary PCI
Chen Jing6,294 enrolled1 locationNCT07361783
Recruiting

Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK)

Cardiogenic ShockCardiogenic Shock AcuteCardiogenic Shock Post Myocardial Infarction
Hospital de Santa Cruz, Portugal800 enrolled1 locationNCT07597291
Recruiting
Not Applicable

The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial

Myocardial Infarction (MI)Chest Pain Rule Out Myocardial Infarction
CHA University4,670 enrolled12 locationsNCT07027891
Recruiting

BEAT-SHOCK Registry

Cardiogenic ShockMyocardial Infarction (MI)Acute Decompensated Heart Failure+4 more
University Hospital, Basel, Switzerland8,000 enrolled1 locationNCT07643610
Recruiting
Not Applicable

Arrhythmia Detection After MI

Acute Myocardial Infarction
Samir Saba200 enrolled1 locationNCT05073419
Recruiting
Phase 1

The Pharmacokinetics and Pharmacodynamics Study of CG-0255 Besylate and Plavix® in Healthy Participants

Peripheral Arterial DiseaseRecent Myocardial InfarctionRecent Stroke+1 more
Shanghai CureGene Pharmaceutical Co., Ltd.136 enrolled1 locationNCT07619885
Recruiting
Not Applicable

TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome

Myocardial InfarctionAcute Coronary Syndrome (ACS)
Columbia University250 enrolled1 locationNCT07541014
Recruiting

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Heart FailureCardiotoxicityMyocardial Infarction+12 more
Peerbridge Health, Inc2,000 enrolled8 locationsNCT06699056
Recruiting

OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science

Cardiogenic ShockMechanical Circulatory SupportCardiogenic Shock Post Myocardial Infarction
Medical University of Vienna100 enrolled1 locationNCT07619144
Recruiting
Not Applicable

Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction

left ventricular thrombusST-segment elevation myocardial infarction (STEMI)
Jilin University320 enrolled1 locationNCT05892042
Recruiting

Ventricular Arrhythmias in Acute Myocardial Infarction

Ventricular ArrhythmiaAcute Myocardial Infarction (AMI)
Poitiers University Hospital500 enrolled8 locationsNCT07517523
Recruiting
Not Applicable

Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI

ST Elevation Myocardial Infarction
Hospital Universitario La Fe1,272 enrolled23 locationsNCT06353594
Recruiting

Machine Learning for Diagnosis of Occlusive MI in LBBB Patients

Myocardial InfarctionChest PainLeft Bundle-Branch Block+2 more
Konya City Hospital50 enrolled1 locationNCT07620119
Recruiting
Not Applicable

Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells

Coronary Artery DiseaseMyocardial Infarction (MI)CABG
Cambridge University Hospitals NHS Foundation Trust24 enrolled2 locationsNCT07610538
Recruiting
Phase 4

Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions

Myocardial InfarctionAcute Heart Failure (AHF)Arrhythmias+3 more
Wroclaw Medical University400 enrolled1 locationNCT07617376
Recruiting
Phase 4

Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden

ST-segment elevation myocardial infarction (STEMI)
Henan Institute of Cardiovascular Epidemiology300 enrolled1 locationNCT06769256
Recruiting
Not Applicable

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Ischemic Heart DiseaseST Segment Elevation Myocardial Infarction
Thomas Engstrom150 enrolled1 locationNCT02445885
Recruiting
Phase 2

A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction

Anterior Myocardial Infarction
Beijing Sungen Biomedical Technology Co., Ltd210 enrolled1 locationNCT07306182
Recruiting
Not Applicable

Cohort of STEMI Patients 2

Myocardial Infarction
Hospices Civils de Lyon300 enrolled2 locationsNCT05794022
Recruiting

Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome

Unstable Angina PectorisST Elevation (STEMI) Myocardial InfarctionNon ST Elevation Myocardial Infarction (NSTEMI)
Clinical Center Niš550 enrolled1 locationNCT07366684